UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

The Lancet (British edition), 2008-06, Vol.371 (9629), p.1999-2012

2008

Volltextzugriff (PDF)

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Journal of internal medicine, 2006-03, Vol.259 (3), p.247-258

2006

Volltextzugriff (PDF)

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease

Journal of internal medicine, 2006-05, Vol.259 (5), p.434-436

FAERGEMAN, O.

2006

Volltextzugriff (PDF)

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Diabetes care, 1997-04, Vol.20 (4), p.614

1997

Volltextzugriff (PDF)

Upper-Limb Thrombo-Embolectomy: National Cohort Study in Denmark

European journal of vascular and endovascular surgery, 2010-11, Vol.40 (5), p.628-634

2010

Volltextzugriff (PDF)

Genes and cardiovascular risk

European heart journal, 2013-04, Vol.34 (13), p.949-950

Faergeman, Ole

2013

Volltextzugriff (PDF)

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering

The American journal of cardiology, 2000-08, Vol.86 (3), p.257-262

2000

Volltextzugriff (PDF)

Atrial fibrillation and upper limb thromboembolectomy: a national cohort study

Journal of thrombosis and haemostasis, 2011-09, Vol.9 (9), p.1738-1743

2011

Volltextzugriff (PDF)

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial

Journal of internal medicine, 2010-06, Vol.267 (6), p.567-575

2010

Volltextzugriff (PDF)

A collective failure of medical practice?

European heart journal, 2001-04, Vol.22 (7), p.526-528

Faergeman, O

2001

Volltextzugriff (PDF)

Estimation and reduction of cardiovascular risk in old people

European heart journal, 2002-02, Vol.23 (4), p.261-263

Faergeman, O

2002

Volltextzugriff (PDF)

Upper-Limb Thrombo-Embolectomy: National Cohort Study in Denmark

Journal of vascular surgery, 2010-11, Vol.52 (5), p.1423-1423

2010

Volltextzugriff (PDF)

Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study

The American journal of cardiology, 2004-09, Vol.94 (6), p.720-724

2004

Volltextzugriff (PDF)

The societal context of coronary artery disease

European Heart Journal Supplements, 2005-03, Vol.7 (suppl-A), p.A5-A11

Færgeman, O.

2005

Volltextzugriff (PDF)

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2005-11, Vol.294 (19), p.2437

2005

Volltextzugriff (PDF)

Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons

Journal of epidemiology and community health (1979), 2006-08, Vol.60 (8), p.721-728

2006

Volltextzugriff (PDF)

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)

The Lancet (British edition), 2004-08, Vol.364 (9436), p.771-777

2004

Volltextzugriff (PDF)

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

Journal of the American College of Cardiology, 2008-02, Vol.51 (6), p.634-642

2008

Volltextzugriff (PDF)

Simvastatin seems unlikely to cause impotence [letter]

BMJ. British medical journal (International ed.), 1999-01, Vol.318 (7177), p.192

International edition, 1999

Volltextzugriff (PDF)

Prevention of coronary heart disease in clinical practice

European heart journal, 1998-10, Vol.19 (10), p.1434-1503

1998

Volltextzugriff (PDF)

High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing

Clinical chemistry (Baltimore, Md.), 1996-08, Vol.42 (8), p.1140-1146

1996

Volltextzugriff (PDF)

New British recommendations for prevention of coronary heart disease in clinical practice

Heart (British Cardiac Society), 1999-04, Vol.81 (4), p.335-335

FAERGEMAN, OLE

1999

Volltextzugriff (PDF)

Prevention of coronary heart disease in clinical practice : Recommendations of the second joint task force of european and other societies on coronary prevention

European heart journal, 1998-10, Vol.19 (10), p.1434-1503

1998

Volltextzugriff (PDF)

Principles for national and regional guidelines on cardiovascular disease prevention: A scientific statement from the World Heart and Stroke Forum

Circulation (New York, N.Y.), 2004-06, Vol.109 (25), p.3112-3121

2004

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(282)
Berichte
(1)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(191)
Science & Technology
(135)
Life Sciences & Biomedicine
(134)
Male
(130)
Female
(105)
Middle Aged
(98)
Biological And Medical Sciences
(93)
Adult
(89)
Medical Sciences
(83)
Aged
(62)
Cardiovascular System & Cardiology
(45)
Cardiac & Cardiovascular Systems
(37)
Risk Factors
(37)
Cholesterol - Blood
(34)
Receptors, Ldl - Genetics
(32)
Metabolic Diseases
(29)
Coronary Heart Disease
(28)
Genetics & Heredity
(28)
Hyperlipoproteinemia Type Ii - Genetics
(26)
Lipids - Blood
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Upper-Limb Thrombo-Embolectomy: National Cohort Study in Denmark

Genes and cardiovascular risk

Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering

Atrial fibrillation and upper limb thromboembolectomy: a national cohort study

Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial

A collective failure of medical practice?

Estimation and reduction of cardiovascular risk in old people

Upper-Limb Thrombo-Embolectomy: National Cohort Study in Denmark

Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study

The societal context of coronary artery disease

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)

European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

Simvastatin seems unlikely to cause impotence [letter]

Prevention of coronary heart disease in clinical practice

High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing

New British recommendations for prevention of coronary heart disease in clinical practice

Prevention of coronary heart disease in clinical practice : Recommendations of the second joint task force of european and other societies on coronary prevention

Principles for national and regional guidelines on cardiovascular disease prevention: A scientific statement from the World Heart and Stroke Forum

Suchergebnisse filtern